Internet Content & Information
Compare Stocks
5 / 10Stock Comparison
NN vs NOVT vs TRMB vs CGNX vs VIAV
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Communication Equipment
NN vs NOVT vs TRMB vs CGNX vs VIAV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Internet Content & Information | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Communication Equipment |
| Market Cap | $2.64B | $4.86B | $14.65B | $11.01B | $11.81B |
| Revenue (TTM) | $5M | $981M | $3.69B | $1.05B | $1.37B |
| Net Income (TTM) | $-189M | $54M | $456M | $143M | $-55M |
| Gross Margin | -256.2% | 44.4% | 68.8% | 68.0% | 55.7% |
| Operating Margin | -15.4% | 11.9% | 17.7% | 18.8% | 8.2% |
| Forward P/E | — | 38.2x | 20.0x | 53.0x | 55.2x |
| Total Debt | $15M | $342M | $1.39B | $77M | $692M |
| Cash & Equiv. | $45M | $381M | $253M | $263M | $424M |
NN vs NOVT vs TRMB vs CGNX vs VIAV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| NextNav Inc. (NN) | 100 | 197.1 | +97.1% |
| Novanta Inc. (NOVT) | 100 | 113.6 | +13.6% |
| Trimble Inc. (TRMB) | 100 | 103.3 | +3.3% |
| Cognex Corporation (CGNX) | 100 | 87.7 | -12.3% |
| Viavi Solutions Inc. (VIAV) | 100 | 376.9 | +276.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NN vs NOVT vs TRMB vs CGNX vs VIAV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NN is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 1.33, current ratio 12.71x
- Beta 1.33, current ratio 12.71x
- Beta 1.33 vs NOVT's 2.02
Among these 5 stocks, NOVT doesn't own a clear edge in any measured category.
TRMB ranks third and is worth considering specifically for valuation efficiency.
- PEG 8.15 vs VIAV's 12.09
- Lower P/E (20.0x vs 55.2x), PEG 8.15 vs 12.09
CGNX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 4 yrs, beta 1.50, yield 0.5%
- Rev growth 8.7%, EPS growth 9.7%, 3Y rev CAGR -0.4%
- 8.7% revenue growth vs NN's -19.3%
- 13.6% margin vs NN's -41.4%
VIAV is the clearest fit if your priority is long-term compounding.
- 7.2% 10Y total return vs NOVT's 8.5%
- +466.6% vs TRMB's -6.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.7% revenue growth vs NN's -19.3% | |
| Value | Lower P/E (20.0x vs 55.2x), PEG 8.15 vs 12.09 | |
| Quality / Margins | 13.6% margin vs NN's -41.4% | |
| Stability / Safety | Beta 1.33 vs NOVT's 2.02 | |
| Dividends | 0.5% yield; 4-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +466.6% vs TRMB's -6.7% | |
| Efficiency (ROA) | 7.1% ROA vs NN's -73.1% |
NN vs NOVT vs TRMB vs CGNX vs VIAV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NN vs NOVT vs TRMB vs CGNX vs VIAV — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CGNX leads in 3 of 6 categories
TRMB leads 1 • VIAV leads 1 • NN leads 0 • NOVT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CGNX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TRMB is the larger business by revenue, generating $3.7B annually — 806.2x NN's $5M. CGNX is the more profitable business, keeping 13.6% of every revenue dollar as net income compared to NN's -41.4%. On growth, VIAV holds the edge at +42.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5M | $981M | $3.7B | $1.0B | $1.4B |
| EBITDAEarnings before interest/tax | -$62M | $179M | $785M | $219M | $207M |
| Net IncomeAfter-tax profit | -$189M | $54M | $456M | $143M | -$55M |
| Free Cash FlowCash after capex | -$51M | $48M | $253M | $241M | $46M |
| Gross MarginGross profit ÷ Revenue | -2.6% | +44.4% | +68.8% | +68.0% | +55.7% |
| Operating MarginEBIT ÷ Revenue | -15.4% | +11.9% | +17.7% | +18.8% | +8.2% |
| Net MarginNet income ÷ Revenue | -41.4% | +5.5% | +12.4% | +13.6% | -4.0% |
| FCF MarginFCF ÷ Revenue | -11.2% | +4.9% | +6.9% | +23.0% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -50.5% | +8.5% | +11.8% | +24.3% | +42.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -85.2% | -2.2% | +55.6% | +121.4% | -70.2% |
Valuation Metrics
TRMB leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 35.3x trailing earnings, TRMB trades at a 90% valuation discount to VIAV's 340.3x P/E. Adjusting for growth (PEG ratio), TRMB offers better value at 14.39x vs VIAV's 74.57x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.6B | $4.9B | $14.7B | $11.0B | $11.8B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $4.8B | $15.8B | $10.8B | $12.1B |
| Trailing P/EPrice ÷ TTM EPS | -13.74x | 92.71x | 35.34x | 96.92x | 340.33x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 38.25x | 20.01x | 53.05x | 55.18x |
| PEG RatioP/E ÷ EPS growth rate | — | 28.13x | 14.39x | — | 74.57x |
| EV / EBITDAEnterprise value multiple | — | 27.00x | 20.05x | 55.96x | 90.43x |
| Price / SalesMarket cap ÷ Revenue | 577.54x | 4.96x | 4.08x | 11.07x | 10.89x |
| Price / BookPrice ÷ Book value/share | — | 3.81x | 2.54x | 7.48x | 14.77x |
| Price / FCFMarket cap ÷ FCF | — | 100.38x | 110.00x | 46.49x | 190.52x |
Profitability & Efficiency
CGNX leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CGNX delivers a 9.6% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-7 for VIAV. CGNX carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to VIAV's 0.89x. On the Piotroski fundamental quality scale (0–9), CGNX scores 7/9 vs NN's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +4.1% | +8.0% | +9.6% | -6.9% |
| ROA (TTM)Return on assets | -73.1% | +3.0% | +5.0% | +7.1% | -2.3% |
| ROICReturn on invested capital | — | +7.4% | +6.8% | +9.0% | +5.5% |
| ROCEReturn on capital employed | -36.6% | +8.3% | +7.8% | +8.9% | +4.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 5 | 7 | 5 |
| Debt / EquityFinancial leverage | — | 0.26x | 0.24x | 0.05x | 0.89x |
| Net DebtTotal debt minus cash | -$30M | -$39M | $1.1B | -$186M | $269M |
| Cash & Equiv.Liquid assets | $45M | $381M | $253M | $263M | $424M |
| Total DebtShort + long-term debt | $15M | $342M | $1.4B | $77M | $692M |
| Interest CoverageEBIT ÷ Interest expense | -5.64x | 4.89x | 12.26x | — | 2.70x |
Total Returns (Dividends Reinvested)
VIAV leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VIAV five years ago would be worth $31,204 today (with dividends reinvested), compared to $7,797 for TRMB. Over the past 12 months, VIAV leads with a +466.6% total return vs TRMB's -6.7%. The 3-year compound annual growth rate (CAGR) favors NN at 109.2% vs NOVT's -5.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.3% | +22.6% | -21.0% | +78.7% | +181.3% |
| 1-Year ReturnPast 12 months | +41.4% | +14.6% | -6.7% | +133.1% | +466.6% |
| 3-Year ReturnCumulative with dividends | +816.0% | -15.2% | +30.1% | +34.7% | +461.0% |
| 5-Year ReturnCumulative with dividends | +96.1% | +5.7% | -22.0% | -13.2% | +212.0% |
| 10-Year ReturnCumulative with dividends | +100.1% | +853.7% | +166.8% | +249.6% | +715.5% |
| CAGR (3Y)Annualised 3-year return | +109.2% | -5.3% | +9.2% | +10.4% | +77.7% |
Risk & Volatility
Evenly matched — NN and CGNX each lead in 1 of 2 comparable metrics.
Risk & Volatility
NN is the less volatile stock with a 1.33 beta — it tends to amplify market swings less than NOVT's 2.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CGNX currently trades 91.7% from its 52-week high vs TRMB's 70.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.33x | 2.02x | 1.46x | 1.50x | 1.54x |
| 52-Week HighHighest price in past year | $24.19 | $149.95 | $87.50 | $71.90 | $60.43 |
| 52-Week LowLowest price in past year | $10.84 | $98.27 | $61.63 | $27.82 | $8.87 |
| % of 52W HighCurrent price vs 52-week peak | +80.7% | +90.9% | +70.7% | +91.7% | +84.5% |
| RSI (14)Momentum oscillator 0–100 | 55.2 | 62.6 | 36.8 | 76.3 | 66.7 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 375K | 1.7M | 2.0M | 6.3M |
Analyst Outlook
CGNX leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NN as "Buy", NOVT as "Buy", TRMB as "Buy", CGNX as "Hold", VIAV as "Buy". Consensus price targets imply 53.6% upside for TRMB (target: $95) vs -36.8% for VIAV (target: $32). CGNX is the only dividend payer here at 0.49% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $26.33 | $150.00 | $95.00 | $60.22 | $32.25 |
| # AnalystsCovering analysts | 3 | 3 | 28 | 31 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.5% | — |
| Dividend StreakConsecutive years of raises | — | — | — | 4 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $0.32 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% | +5.9% | +1.4% | +0.1% |
CGNX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TRMB leads in 1 (Valuation Metrics). 1 tied.
NN vs NOVT vs TRMB vs CGNX vs VIAV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NN or NOVT or TRMB or CGNX or VIAV a better buy right now?
For growth investors, Cognex Corporation (CGNX) is the stronger pick with 8.
7% revenue growth year-over-year, versus -19. 3% for NextNav Inc. (NN). Trimble Inc. (TRMB) offers the better valuation at 35. 3x trailing P/E (20. 0x forward), making it the more compelling value choice. Analysts rate NextNav Inc. (NN) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NN or NOVT or TRMB or CGNX or VIAV?
On trailing P/E, Trimble Inc.
(TRMB) is the cheapest at 35. 3x versus Viavi Solutions Inc. at 340. 3x. On forward P/E, Trimble Inc. is actually cheaper at 20. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Trimble Inc. wins at 8. 15x versus Viavi Solutions Inc. 's 12. 09x.
03Which is the better long-term investment — NN or NOVT or TRMB or CGNX or VIAV?
Over the past 5 years, Viavi Solutions Inc.
(VIAV) delivered a total return of +212. 0%, compared to -22. 0% for Trimble Inc. (TRMB). Over 10 years, the gap is even starker: NOVT returned +853. 7% versus NN's +100. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NN or NOVT or TRMB or CGNX or VIAV?
By beta (market sensitivity over 5 years), NextNav Inc.
(NN) is the lower-risk stock at 1. 33β versus Novanta Inc. 's 2. 02β — meaning NOVT is approximately 52% more volatile than NN relative to the S&P 500. On balance sheet safety, Cognex Corporation (CGNX) carries a lower debt/equity ratio of 5% versus 89% for Viavi Solutions Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NN or NOVT or TRMB or CGNX or VIAV?
By revenue growth (latest reported year), Cognex Corporation (CGNX) is pulling ahead at 8.
7% versus -19. 3% for NextNav Inc. (NN). On earnings-per-share growth, the picture is similar: Viavi Solutions Inc. grew EPS 225. 0% year-over-year, compared to -71. 3% for Trimble Inc.. Over a 3-year CAGR, NN leads at 5. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NN or NOVT or TRMB or CGNX or VIAV?
Trimble Inc.
(TRMB) is the more profitable company, earning 11. 8% net margin versus -41. 4% for NextNav Inc. — meaning it keeps 11. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRMB leads at 16. 9% versus -1535. 8% for NN. At the gross margin level — before operating expenses — TRMB leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NN or NOVT or TRMB or CGNX or VIAV more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Trimble Inc. (TRMB) is the more undervalued stock at a PEG of 8. 15x versus Viavi Solutions Inc. 's 12. 09x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Trimble Inc. (TRMB) trades at 20. 0x forward P/E versus 55. 2x for Viavi Solutions Inc. — 35. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRMB: 53. 6% to $95. 00.
08Which pays a better dividend — NN or NOVT or TRMB or CGNX or VIAV?
In this comparison, CGNX (0.
5% yield) pays a dividend. NN, NOVT, TRMB, VIAV do not pay a meaningful dividend and should not be held primarily for income.
09Is NN or NOVT or TRMB or CGNX or VIAV better for a retirement portfolio?
For long-horizon retirement investors, Viavi Solutions Inc.
(VIAV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+715. 5% 10Y return). Novanta Inc. (NOVT) carries a higher beta of 2. 02 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VIAV: +715. 5%, NOVT: +853. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NN and NOVT and TRMB and CGNX and VIAV?
These companies operate in different sectors (NN (Communication Services) and NOVT (Technology) and TRMB (Technology) and CGNX (Technology) and VIAV (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.